Ethypharm

Ethypharm is a leading mid-size international specialty pharmaceutical company with strong European roots. The company manufactures and provides essential medicines with a focus on two core therapeutic areas: Central Nervous System (CNS) treatments for severe pain and addiction, and Hospital Injectables for critical care situations.

Core Focus Areas

Central Nervous System (CNS): Ethypharm is deeply engaged in developing and commercializing medicines for severe pain management and addiction treatment, with a commitment to addressing unmet needs in these therapeutic areas.

Hospital Injectables: The company specializes in injectable formulations for hospital and critical care settings, continuously screening opportunities to expand its portfolio in this space.

Company Profile

Ethypharm operates as an agile and dynamic specialty pharmaceutical company with a clear strategy and significant growth ambitions. The organization pursues strategic geographical expansions and maintains commercial teams focused on connecting with customers and making meaningful impact in patients' lives across multiple markets.

Business Development

The company is open to discussing potential partnerships and maintains dedicated business development teams. Ethypharm actively engages in licensing agreements and portfolio expansion, as evidenced by recent agreements to commercialize additional analgesic and pain management products across European markets.